Brain structure, cognition and negative symptoms in schizophrenia are associated with serum levels of polysialic acid-modified NCAM
Fabrizio Piras(Fondazione Santa Lucia), Gianfranco Spalletta(University of Zurich), Carlo Caltagirone(Fondazione Santa Lucia), Herbert Hildebrandt(Medizinische Hochschule Hannover), Melissa A. Schiff(University of New Mexico), Martina Mühlenhoff(Medizinische Hochschule Hannover), Rita Gerardy‐Schahn(Medizinische Hochschule Hannover), Paola Bossù(Fondazione Santa Lucia), Chiara Chiapponi(Fondazione Santa Lucia)
Cited by 45
Related Papers
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
|Molecular Psychiatry|2017|744
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries
|Translational Psychiatry|2020|702
Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta- and Mega-Analysis
|American Journal of Psychiatry|2016|348
Poststroke Depression: A Review
|The Canadian Journal of Psychiatry|2010|316